AMPH vs. CORT
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or CORT.
Key characteristics
| AMPH | CORT | |
|---|---|---|
| YTD Return | -17.83% | 51.20% |
| 1Y Return | 14.23% | 75.90% |
| 3Y Return (Ann) | 38.59% | 38.15% |
| 5Y Return (Ann) | 20.64% | 28.58% |
| 10Y Return (Ann) | 17.62% | 32.22% |
| Sharpe Ratio | 0.33 | 1.41 |
| Sortino Ratio | 0.78 | 1.85 |
| Omega Ratio | 1.10 | 1.29 |
| Calmar Ratio | 0.31 | 2.01 |
| Martin Ratio | 0.51 | 4.19 |
| Ulcer Index | 26.31% | 18.01% |
| Daily Std Dev | 40.57% | 53.51% |
| Max Drawdown | -49.92% | -94.28% |
| Current Drawdown | -21.82% | -1.29% |
Fundamentals
| AMPH | CORT | |
|---|---|---|
| Market Cap | $2.49B | $5.13B |
| EPS | $3.15 | $1.13 |
| PE Ratio | 16.14 | 43.46 |
| PEG Ratio | 2.77 | 0.61 |
| Total Revenue (TTM) | $532.34M | $446.01M |
| Gross Profit (TTM) | $272.90M | $439.07M |
| EBITDA (TTM) | $199.10M | $97.77M |
Correlation
The correlation between AMPH and CORT is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMPH vs. CORT - Performance Comparison
In the year-to-date period, AMPH achieves a -17.83% return, which is significantly lower than CORT's 51.20% return. Over the past 10 years, AMPH has underperformed CORT with an annualized return of 17.62%, while CORT has yielded a comparatively higher 32.22% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMPH vs. CORT - Dividend Comparison
Neither AMPH nor CORT has paid dividends to shareholders.
Drawdowns
AMPH vs. CORT - Drawdown Comparison
The maximum AMPH drawdown since its inception was -49.92%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for AMPH and CORT. For additional features, visit the drawdowns tool.
Volatility
AMPH vs. CORT - Volatility Comparison
The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 8.79%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 10.45%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMPH vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities